价格

Approvals/FDA/drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium

Approved

HUMAN PRESCRIPTION DRUG LABEL

d9fee8fbca2f6489

drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 8, 2025
Approval ID: 48f4301c-0426-43cd-af37-c4d8fc7aeb67
Products: 1 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS safely and effectively. See full prescribing information for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM TABLETS AND LEVOMEFOLATE CALCIUM TABLETS. DROSPIRENONE, ETHINYL ESTRADIOL and LEVOMEFOLATE CALCIUM Tablets and LEVOMEFOLATE CALCIUM Tablets, for oral use Initial U.S. Approval: 2010

Quick Stats

Total Products1

Labelers2

Label Sections41

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.